Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-15

FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Glenmark Pharmaceutials Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for rosuvastatin calcium from Glenmark Pharmaceuticals, confirming regulatory approval of this generic statin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)